Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Assets: 2013-2024

Historic Current Assets for Fortress Biotech (FBIO) over the last 12 years, with Dec 2024 value amounting to $90.4 million.

  • Fortress Biotech's Current Assets rose 37.35% to $118.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.5 million, marking a year-over-year increase of 37.35%. This contributed to the annual value of $90.4 million for FY2024, which is 22.77% down from last year.
  • As of FY2024, Fortress Biotech's Current Assets stood at $90.4 million, which was down 22.77% from $117.0 million recorded in FY2023.
  • Over the past 5 years, Fortress Biotech's Current Assets peaked at $346.5 million during FY2021, and registered a low of $90.4 million during FY2024.
  • For the 3-year period, Fortress Biotech's Current Assets averaged around $145.9 million, with its median value being $117.0 million (2023).
  • As far as peak fluctuations go, Fortress Biotech's Current Assets soared by 70.33% in 2020, and later tumbled by 49.22% in 2023.
  • Over the past 5 years, Fortress Biotech's Current Assets (Yearly) stood at $266.1 million in 2020, then spiked by 30.18% to $346.5 million in 2021, then tumbled by 33.49% to $230.4 million in 2022, then plummeted by 49.22% to $117.0 million in 2023, then fell by 22.77% to $90.4 million in 2024.